Clarifying the Differences in Orphan Drug Designation Between the EMA & FDA
Time: 9:30 am
day: Day Two
Details:
- Highlight the key strategic differences between the two bodies for success in gaining Orphan drug designations
- Explore the main incentives related to Orphan designations
- Understand the concept of similarity for Orphan drug exclusivity
